0001144204-17-044223.txt : 20170818
0001144204-17-044223.hdr.sgml : 20170818
20170818172648
ACCESSION NUMBER: 0001144204-17-044223
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170313
FILED AS OF DATE: 20170818
DATE AS OF CHANGE: 20170818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAMAD AKHTAR
CENTRAL INDEX KEY: 0001645047
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38114
FILM NUMBER: 171041753
MAIL ADDRESS:
STREET 1: 332 BLEECKER STREET
STREET 2: #239
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001644963
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474113275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
3
1
v473693_form3.xml
FORM 3
X0206
3
2017-03-13
0
0001644963
AVENUE THERAPEUTICS, INC.
ATXI
0001645047
SAMAD AKHTAR
C/O AVENUE THERAPEUTICS, INC.
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
Common Stock (Restricted)
50000
D
The 50,000 shares of restricted Common Stock will vest as follows: One-third on August 8, 2020, one-third on August 8, 2021 and one-third on August 8, 2022.
/s/ Lucy Lu, M.D., Attorney-in-Fact
2017-08-18